Patent · US Active

Methods for identifying androgen receptor splice variants in subjects having castration resistant prostate cancer

US10774387B2 · kind B2 · utility

1Cited by

29References

18Claims

0Family size

Assignee

THE JOHNS HOPKINS UNIVERSITY · US

Inventors

Jun Luo · Belmont, US
Emmanuel S. Antaonarakis · Cumberland, US
Changxue Lu · Chengdu, CN

Key dates

Filing date	May 19, 2015
Grant date	Sep 15, 2020
Priority date	—
Expiry date	Oct 9, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/156
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Methods of the present disclosure provide for detection of mutations and splice variants of the androgen receptor using a non-invasive approach, RNAseq, for examining circulating tumor cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.